Methods | Trial with both randomised and open label arms | |
Participants | Bipolar disorder and schizoaffective disorder | |
Interventions | 8 on oxcarbazepine, 7 on lithium. 5 of these were open label | |
Outcomes | Relapse of disorder | |
Notes | 33 month study . Method of randomisation was not clear. Method of analysing open label patients, if analysed separately, from randomised group was not described. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | High risk | C ‐ Inadequate |